Caricamento...

Perimenopausal Transdermal Estradiol Replacement Reduces Serum HDL Cholesterol Efflux Capacity but Improves Cardiovascular Risk Factors

BACKGROUND: The cardiovascular (CV) safety of estrogen replacement therapy (ERT) in perimenopausal women remains uncertain. Although exogenous estrogens increase HDL cholesterol (HDL-C), estrogen-mediated effects on alternative metrics of HDL that may better predict CV risk are unknown. OBJECTIVE: T...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Lipidol
Autori principali: Vaisar, Tomas, Gordon, Jennifer L, Wimberger, Jake, Heinecke, Jay W, Hinderliter, Alan L, Rubinow, David R, Girdler, Susan S, Rubinow, Katya B
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7887026/
https://ncbi.nlm.nih.gov/pubmed/33288437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacl.2020.11.009
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !